In this expert commentary, contemporary therapy for patients with resectable and advanced pancreatic cancer are discussed, with a focus on neoadjuvant and adjuvant therapy strategies and targeted therapies for cancers with actionable mutations.
Download this concise slideset for expert perspectives on first-line systemic therapy considerations for patients with advanced pancreatic cancer.
Download this concise slideset for expert perspectives on second-line systemic therapy considerations for patients with advanced pancreatic cancer.
This brief activity provides expert insights into the selection of first-line systemic therapy for patients with advanced pancreatic cancer based on best available evidence.
This short activity provides expert insights into selection of second-line systemic therapy for patients with advanced pancreatic cancer.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.